Article

Weight lifting and lymphedema

Author(s):

In the past, weight lifting has generally been discouraged for breast cancer survivors who have lymphedema. But a recent study, published in The New England Journal of Medicine, reveals that weight lifting may not be so harmful, and actually may benefit survivors.A total of 141 women were randomized for this study with half of the survivors entering a twice-weekly progressive weight-lifting program and half as the control group. Participants were required to wear compression sleeves while weight lifting, trained by certified fitness professionals, and assessed by lymphedema specialists on a regular basis.Researchers concluded, "In breast-cancer survivors with lymphedema, slowly progressive weight lifting had no significant effect on limb swelling and resulted in a decreased incidence of exacerbations of lymphedema, reduced symptoms, and increased strength." Another interesting aspect of this study was the fitness centers used were YMCAs that host the LIVESTRONG program, a collaboration between the Lance Armstrong Foundation and the YMCA to develop programs specifically for cancer survivors and to certify trainers who understand the special needs of survivor population.But before you start pumping iron, make sure you check with your doctor, nurse, or physical therapist to see if you are ready to start a program and find a certified trainer who is trained to work with lymphedema patients and can show you the exercises that will help.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content